Biological Sciences and Healthcare, part 5

... > Clinical finding (finding) > Propensity to adverse reactions (disorder) > Propensity to adverse reactions to substance (disorder) > Allergy to substance (disorder) > Drug allergy (disorder) > Allergy to reverse transcriptase inhibitor > Allergy to abacavir

... > Clinical finding (finding) > Hypersensitivity condition > Hypersensitivity disposition > allergy > Allergy to substance (disorder) > Drug allergy (disorder) > Allergy to reverse transcriptase inhibitor > Allergy to abacavir

... > Clinical finding (finding) > Propensity to adverse reactions (disorder) > Hypersensitivity disposition > allergy > Allergy to substance (disorder) > Drug allergy (disorder) > Allergy to reverse transcriptase inhibitor > Allergy to abacavir

... > Clinical finding (finding) > Hypersensitivity condition > Allergic condition > allergy > Allergy to substance (disorder) > Drug allergy (disorder) > Allergy to reverse transcriptase inhibitor > Allergy to abacavir

... > Clinical finding (finding) > Propensity to adverse reactions (disorder) > Propensity to adverse reactions to substance (disorder) > Propensity to adverse reactions to drug (disorder) > Drug allergy (disorder) > Allergy to reverse transcriptase inhibitor > Allergy to abacavir